What are the diagnostic criteria for Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Diabetic Ketoacidosis (DKA)

DKA is diagnosed when all three components are present simultaneously: blood glucose >250 mg/dL, venous pH <7.3 with serum bicarbonate <15 mEq/L, and elevated blood β-hydroxybutyrate (β-OHB). 1, 2

Core Diagnostic Triad

All three criteria must be met for DKA diagnosis:

  • Hyperglycemia: Blood glucose >250 mg/dL 1, 3, 2

    • Note: This threshold has been de-emphasized due to increasing euglycemic DKA, particularly with SGLT2 inhibitor use 3, 4
    • Euglycemic DKA (glucose <250 mg/dL with ketoacidosis) is increasingly common and should not exclude the diagnosis 3
  • Metabolic Acidosis: Venous pH <7.3 AND serum bicarbonate <15 mEq/L 1, 3, 2

    • Anion gap should be >10-12 mEq/L, calculated as [Na⁺] - ([Cl⁻] + [HCO₃⁻]) 1, 2
  • Ketosis: Elevated blood ketones, preferably measured as β-hydroxybutyrate 1, 3, 2

    • Direct blood β-OHB measurement is the gold standard 1, 3, 2

Severity Classification

DKA severity determines monitoring intensity and prognosis:

  • Mild DKA: pH 7.25-7.30, bicarbonate 15-18 mEq/L, alert mental status 1, 3, 2

  • Moderate DKA: pH 7.00-7.24, bicarbonate 10-15 mEq/L, drowsy/lethargic mental status 1, 3, 2

  • Severe DKA: pH <7.00, bicarbonate <10 mEq/L, stuporous or comatose mental status, associated with higher morbidity and mortality 1, 3, 2

Essential Laboratory Workup

Obtain immediately upon presentation:

  • Complete metabolic panel (sodium, potassium, chloride, bicarbonate, BUN, creatinine, glucose) 1, 3, 2
  • Venous blood gas (pH, pCO2, bicarbonate) 1, 3, 2
  • Blood β-hydroxybutyrate (β-OHB) - preferred ketone measurement 1, 3, 2
  • Complete blood count with differential 1, 3, 2
  • Urinalysis 1, 3, 2
  • Serum osmolality 3, 2
  • Electrocardiogram 3, 2
  • Calculate anion gap 1, 2
  • Correct serum sodium for hyperglycemia: [measured Na (mEq/L)] + [glucose (mg/dL) - 100]/100 × 1.6 1

Additional tests to consider based on clinical presentation:

  • Bacterial cultures (blood, urine, throat) if infection suspected 1
  • Amylase/lipase if abdominal pain present 4
  • Troponin, creatine kinase if cardiac symptoms 4
  • Chest radiography if respiratory symptoms 4

Critical Ketone Measurement Considerations

Never rely on urine ketones or nitroprusside-based tests for diagnosis or monitoring. 1, 3, 2

  • The nitroprusside method only measures acetoacetate and acetone, completely missing β-OHB—the predominant and strongest ketoacid in DKA 1, 3
  • During treatment, β-OHB is converted to acetoacetate, which paradoxically makes nitroprusside tests appear worse even as the patient improves 1
  • Blood β-OHB measurement is superior for both diagnosis and monitoring 1, 3, 2

Resolution Criteria

DKA is resolved when ALL of the following are met:

  • Glucose <200 mg/dL 1, 2
  • Venous pH >7.3 1, 3, 2
  • Serum bicarbonate ≥18 mEq/L 1, 3, 2
  • Anion gap ≤12 mEq/L 1, 3, 2

Common Diagnostic Pitfalls to Avoid

  • Do not dismiss DKA because glucose is <250 mg/dL - euglycemic DKA is increasingly common, especially with SGLT2 inhibitors 3, 4
  • Do not use urine ketones for diagnosis - they miss β-OHB and can be falsely negative early in DKA 1, 3
  • Do not rely solely on arterial blood gases - venous pH (typically 0.03 units lower than arterial) is adequate for diagnosis and monitoring 1
  • Do not stop monitoring ketones prematurely - ketonemia takes longer to clear than hyperglycemia 1, 2

Monitoring During Treatment

Draw blood every 2-4 hours to measure:

  • Electrolytes (sodium, potassium, chloride) 1, 3, 2
  • Glucose 1, 3, 2
  • Venous pH 1, 3, 2
  • β-hydroxybutyrate 1, 3
  • Anion gap 1, 3, 2
  • BUN, creatinine 1, 3, 2
  • Serum osmolality 1, 3, 2

References

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Diabetic Ketoacidosis (DKA) in Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.